International Journal of Experimental Dental Science

Register      Login

VOLUME 10 , ISSUE 1 ( January-June, 2021 ) > List of Articles

REVIEW ARTICLE

SARS-CoV-2 Infection and ACE-2 Expression in Children: An Overview

Jayalakshmi Pandranki, Jai Kiran Killada, Maddula Madhavi Krishna

Keywords : Angiotensin-converting enzyme 2, Clinical manifestations, Coronavirus disease-2019 in children, SARS-CoV-2

Citation Information : Pandranki J, Killada JK, Krishna MM. SARS-CoV-2 Infection and ACE-2 Expression in Children: An Overview. Int J Experiment Dent Sci 2021; 10 (1):19-24.

DOI: 10.5005/jp-journals-10029-1218

License: CC BY-NC 4.0

Published Online: 11-08-2021

Copyright Statement:  Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

SARS-CoV-2 has marked a new era in the medical field with a wide array of signs and symptoms. The clinical manifestations may vary from simple sore throat to severe multiple organ failure causing death in adults. The severity of the disease was relatively mild in children compared to adults but the preliminary evidence reveals high proportions of asymptomatic infection which contributes to a viral transmission. It still remains ambiguous why children are less severely affected than adults. This literature provides a comprehensive review of epidemiology, vulnerability, pathophysiology, organ-specific systemic manifestations of coronavirus disease-2019 (COVID-19), its clinical course similarities and differences between child and adult with a special focus on the reasons behind the reduced disease severity in children.


PDF Share
  1. WHO? Coronavirus Disease 2019 (COVID_19), Situation No. 51; 11th March, 2020.
  2. Coronavirus COVI-19 Global Cases by the Centre for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Available from https://coronavirus.jhu.edu/map.html [Last accessed on 2021 Feb 24].
  3. Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 among children in China. Pediatrics 2020;145(6):e20200702. DOI: 10.1542/peds.2020-0702.
  4. Ogimi C, Englund JA, Bradford MC, et al. Characteristics and outcomes of coronavirus infection in children: the role of viral factors and an immunocompromised state. J Pediatr Infect Dis Soc 2019;8(1):21–28. DOI: 10.1093/jpids/pix093.
  5. Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr 2020;109(6):1088–1095. DOI: 10.1111/apa.15270.
  6. Zou X, Chen K, Zou J, et al. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med 2020;14(2):185–192. DOI: 10.1007/s11684-020-0754-0.
  7. Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol 2020;92(6):552–555. DOI: 10.1002/jmv.25728.
  8. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis 2020;34:101623. DOI: 10.1016/j.tmaid.2020.101623.
  9. Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis 2020;94:91–95. DOI: 10.1016/j.ijid.2020.03.017.
  10. Cao Y, Liu X, Xiong L, et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis. J Med Virol 2020;92(9):1449–1459. DOI: 10.1002/jmv.25822.
  11. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019. novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323(11):1061–1069. DOI: 10.1001/jama.2020.1585.
  12. Kopel J, Perisetti A, Gajendran M, et al. Clinical insights into the gastrointestinal manifestations of COVID-19. Digestive Dis Sci 2020;65(7):1932–1939. DOI: 10.1007/s10620-020-06362-8.
  13. Chen L, Lou J, Bai Y, et al. COVID-19 disease with positive fecal and negative pharyngeal and sputum viral tests. Am J Gastroenterol 2020;115(5):790. DOI: 10.14309/ajg.0000000000000610.
  14. Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med 2020;58(7):1131–1134. DOI: 10.1515/cclm-2020-0198.
  15. Duan XF, Liu Z, Hao R, et al. The dynamic change of liver injury in patients with severe acute respiratory syndrome. Zhonghua Gan Zang Bing Za Zhi 2004;12(7):439.
  16. Li B, Yang J, Zhao F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol 2020;109(5):531–538. DOI: 10.1007/s00392-020-01626-9.
  17. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054–1062. DOI: 10.1016/S0140-6736(20)30566-3.
  18. Yang XH, Sun RH, Chen DC. Diagnosis and treatment of COVID-19: acute kidney injury cannot be ignored. Zhonghua Yi Xue Za Zhi 2020;100(16):1205–1208. DOI: 10.3760/cma.j.cn112137-20200229-00520.
  19. Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;77(6):1–9. DOI: 10.1001/jamaneurol.2020.1127.
  20. Poyiadji N, Shahin G, Noujaim D, et al. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology 2020;296(2):E119–E120. DOI: 10.1148/radiol.2020201187.
  21. Cui Y, Tian M, Huang D, et al. A 55-day-old female infant infected with COVID 19: presenting with pneumonia, liver injury, and heart damage. J Infect Dis 2020;221(11):1775–1781. DOI: 10.1093/infdis/jiaa113.
  22. Villalba NL, Maouche Y, Ortiz MBA, et al. Anosmia and dysgeusia in the absence of other respiratory diseases: should COVID-19 infection be considered? Eur J Case Rep Intern Med 2020;7(4):001641. DOI: 10.12890/2020_001641.
  23. Xu S, Chen M, Weng J. COVID-19 and Kawasaki disease in children. Pharmacol Res 2020;159:104951. DOI: 10.1016/j.phrs.2020.104951.
  24. Qing H, Li Z, Yang Z, et al. The possibility of COVID-19 transmission from eye to nose. Acta Ophthalmol 2020;98(3):e388. DOI: 10.1111/aos.14412.
  25. Ma N, Li P, Wang X, et al. Ocular manifestations and clinical characteristics of children with laboratory-confirmed COVID-19 in Wuhan, China. JAMA Ophthalmol 2020;138(10):1–8.
  26. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol 2020;34(5):e212–e213. DOI: 10.1111/jdv.16387.
  27. Tang K, Wang Y, Zhang H, et al. Cutaneous manifestations of the coronavirus disease 2019 (COVID-19): a brief review [published online ahead of print, 2020 May 7]. Dermatol Ther 2020(4):e13528. DOI: 10.1111/dth.13528.
  28. Xu H, Zhong L, Deng J, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci 2020;12(8). DOI: 10.1038/s41368-020-0074-x.
  29. Lovato A, de Filippis C, Marioni G. Upper airway symptoms in coronavirus disease 2019 (COVID-19). Am J Otolaryngol 2020;41(3):102474. DOI: 10.1016/j.amjoto.2020.102474.
  30. Sabino-Silva R, Jardim ACG, Siqueira WL. Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis. Clin Oral Investig 2020;24(4):1619–1621. DOI: 10.1007/s00784-020-03248-x.
  31. Dziedzic A, Wojtyczka R. The impact of coronavirus infectious disease 19 (COVID-19) on oral health. Oral Dis 2021;27(Suppl 3):703–706. DOI: 10.1111/odi.13359.
  32. Yuen KS, Ye ZW, Fung SY, et al. SARS-CoV-2 and COVID-19: the most important research questions. Cell Biosci 2020;10(1):40. DOI: 10.1186/s13578-020-00404-4.
  33. Amorim Dos Santos J, Normando AGC, Carvalho da Silva RL, et al. Oral mucosal lesions in a COVID-19 patient: new signs or secondary manifestations? Int J Infect Dis 2020;97:326–328. DOI: 10.1016/j.ijid.2020.06.012.
  34. Conti P, Ronconi G, Caraffa A, et al. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by coronavirus-19 (COVID-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents 2020;34(2):327–331. DOI: 10.23812/CONTI-E.
  35. Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: a review. Clin Immunol 2020;215:108427. DOI: 10.1016/j.clim.2020.108427.
  36. Chen ZM, Fu JF, Shu Q, et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J Pediatr 2020;16(3):240–246. DOI: 10.1007/s12519-020-00345-5.
  37. Jones TC, Mühlemann B, Veith T, et al. An analysis of SARS-CoV-2 viral load by patient age. medRxiv 2020. DOI: 10.1101/2020.06.08. 20125484.
  38. Zhou MY, Xie XL, Peng YG, et al. From SARS to COVID-19: what we have learned about children infected with COVID-19. Int J Infect Dis 2020;96:710–714. DOI: 10.1016/j.ijid.2020.04.090.
  39. Peng X, Xu X, Li Y, et al. Transmission routes of 2019-nCoV and controls in dental practice. Int J Oral Sci 2020;12(1):1–6. DOI: 10.1038/s41368-020-0075-9.
  40. Xu J, Li Y, Gan F, et al. Salivary glands: potential reservoirs for COVID-19 asymptomatic infection. J Dent Res 2020;99(8):989. DOI: 10.1177/0022034520918518.
  41. Van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARSCoV-1. New Eng J Med 2020;382(16):1564–1567. DOI: 10.1056/NEJMc2004973.
  42. Xu Y, Li X, Zhu B, et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med 2020;26(4):502–505. DOI: 10.1038/s41591-020-0817-4.
  43. Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J 2020;39(5):355–368. DOI: 10.1097/INF.0000000000002660.
  44. Cao Q, Chen Y, Chen C, et al. SARS-CoV-2 infection in children: transmission dynamics and clinical charateristics. J Formos Med Assoc 2020;119(3):670–673. DOI: 10.1016/j.jfma.2020.02.009.
  45. Henry BM, Lippi G, Plebani M. Laboratory abnormalities in children with novel coronavirus disease 2019. Clin Chem Lab Med 2020;58(7):1135–1138. DOI: 10.1515/cclm-2020-0272.
  46. Henry D, Ackerman M, Sancelme E, et al. Urticarial eruption in COVID-19 infection. J Eur Acad Dermatol Venereol 2020;34(6):e244–e245. DOI: 10.1111/jdv.16472.
  47. Marzano AV, Genovese G, Fabbrocini G, et al. Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients. J Am Acad Dermatol 2020;83(1):280–285. DOI: 10.1016/j.jaad.2020.04.044.
  48. Gianotti R, Veraldi S, Recalcati S, et al. Cutaneous clinico-pathological findings in three COVID-19-positive patients observed in the metropolitan area of Milan, Italy. Acta Derm Venereol 2020;100(8):adv00124. DOI: 10.2340/00015555-3490.
  49. Senthilkumaran S, Meenakshisundaram R, Shah S, et al. Coronavirus disease (COVID-19) in children: Indian perspectives. Indian Pediatr 2020;57(6):585–586. DOI: 10.1007/s13312-020-1869-8.
  50. Balasubramanian S, Rao NM, Goenka A, et al. Coronavirus sisease 2019 (COVID-19) in children - what we know so far and what we do not. Indian Pediatr 2020;57(5):435–442. DOI: 10.1007/s13312-020-1819-5.
  51. Park JY, Han MS, Park KU, et al. First pediatric case of coronavirus disease 2019 in Korea. J Korean Med Sci 2020;35(11):e124. DOI: 10.3346/jkms.2020.35.e124.
  52. Netea MG, Schlitzer A, Placek K, et al. Innate and adaptive immune memory: an evolutionary continuum in the host's response to pathogens. Cell Host Microbe 2019;25(1):13–26. DOI: 10.1016/j.chom.2018.12.006.
  53. Yang J, Chen Y, Yu Z, et al. The influence of PM2.5 on lung injury and cytokines in mice. Exp Ther Med 2019;18(4):2503–2511. DOI: 10.3892/etm.2019.7839.
  54. Wang A, Chiou J, Poirion OB, et al. Single nucleus multiomic profiling reveals age-dynamic regulation of host genes associated with SARS-CoV-2 infection. bioRxiv 2020. DOI: 10.1101/2020.04.12.037580.
  55. Steinman JB, Lum FM, Ho PPK, et al. Reduced development of COVID-19 in children reveals molecular checkpoints gating pathogenesis illuminating potential therapeutics. Proc Natl Acad Sci U S A 2020;117(40):24620–24626. DOI: 10.1073/pnas.2012358117.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.